Acute graft–versus–host disease (aGvHD) is a common complication of allogenic hematopoietic stem cell transplant (allo-HSCT). In this activity, an interprofessional expert panel will discuss 2 physician-submitted cases focused on complications associated with aGvHD therapy, such as thrombocytopenia and infectious complications, and how to address them from a medical, pharmacy, and PA perspective.
Upon completion of this activity, participants should be better able to:
Associate Professor, Pediatrics and Hematology/Oncology
Ingram Professorship, Pediatric Oncology, Department of Pediatrics
Medical Director, Pediatric Stem Cell Transplantation Program
Vanderbilt University Medical Center
Nashville, TN
Clinical Pharmacist Specialist, Stem Cell Transplant & Cellular Therapy
Vanderbilt University Medical Center
Nashville, TN
Associate Director, Advanced Practice Providers – BMT & Immunotherapy
Fred Hutchinson Cancer Center
Teaching Associate, UW Medicine
University of Washington
Seattle, WA
Featured RMEI CE Activities
Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources
